CINECA IRIS Institutional Research Information System

BOMBARDIERI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 42.002
AS - Asia 20.550
EU - Europa 13.405
SA - Sud America 2.576
AF - Africa 749
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 16
Totale 79.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.714
CN - Cina 6.289
SG - Singapore 6.238
IT - Italia 3.476
HK - Hong Kong 3.355
BR - Brasile 2.191
SE - Svezia 2.031
BG - Bulgaria 1.527
VN - Vietnam 1.480
DE - Germania 1.355
CA - Canada 1.078
TR - Turchia 1.077
UA - Ucraina 907
GB - Regno Unito 882
FI - Finlandia 814
FR - Francia 713
KR - Corea 704
RU - Federazione Russa 658
CH - Svizzera 380
IN - India 361
JP - Giappone 285
CI - Costa d'Avorio 177
AR - Argentina 138
NG - Nigeria 128
AT - Austria 123
BE - Belgio 119
SN - Senegal 118
MX - Messico 115
BD - Bangladesh 113
IQ - Iraq 95
NL - Olanda 91
EG - Egitto 69
ID - Indonesia 69
ES - Italia 67
MA - Marocco 63
ZA - Sudafrica 62
CO - Colombia 58
SA - Arabia Saudita 58
IL - Israele 53
AU - Australia 50
EC - Ecuador 47
PK - Pakistan 47
UZ - Uzbekistan 46
PL - Polonia 45
VE - Venezuela 43
KE - Kenya 34
PT - Portogallo 34
IR - Iran 30
JO - Giordania 29
IE - Irlanda 28
CL - Cile 27
PY - Paraguay 26
TN - Tunisia 26
BJ - Benin 22
GR - Grecia 22
HU - Ungheria 22
MY - Malesia 22
NP - Nepal 22
PE - Perù 22
PH - Filippine 20
LT - Lituania 18
TW - Taiwan 18
RO - Romania 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 14
NZ - Nuova Zelanda 14
AL - Albania 13
AZ - Azerbaigian 13
CR - Costa Rica 13
CZ - Repubblica Ceca 13
EU - Europa 13
JM - Giamaica 13
KZ - Kazakistan 13
TH - Thailandia 12
OM - Oman 11
PA - Panama 11
PS - Palestinian Territory 10
RS - Serbia 10
TT - Trinidad e Tobago 10
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
BH - Bahrain 8
HN - Honduras 8
LB - Libano 8
BB - Barbados 7
DK - Danimarca 7
GH - Ghana 7
BY - Bielorussia 6
ET - Etiopia 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
BO - Bolivia 5
CG - Congo 5
KW - Kuwait 5
LK - Sri Lanka 5
MN - Mongolia 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
Totale 79.288
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.445
Ashburn 3.809
Singapore 3.559
Hong Kong 3.321
Ann Arbor 3.233
Fairfield 2.953
Chandler 2.906
Houston 2.609
Santa Clara 1.848
San Jose 1.842
Dallas 1.595
Sofia 1.525
Shanghai 1.354
Seattle 1.256
Milan 1.217
Beijing 1.200
Jacksonville 1.174
Wilmington 1.118
Cambridge 1.029
New York 952
Ottawa 942
Hefei 932
Boardman 700
Seoul 675
Izmir 671
Princeton 636
Nanjing 603
Medford 573
Lawrence 571
Lauterbourg 509
Los Angeles 432
Des Moines 404
Bern 360
Ho Chi Minh City 335
Dearborn 283
Istanbul 278
Dong Ket 253
Council Bluffs 246
Tokyo 243
Hanoi 231
Buffalo 229
Nanchang 214
Jüchen 206
Bremen 201
The Dalles 191
Columbus 183
Serra 179
Abidjan 177
São Paulo 169
Florence 166
Redondo Beach 164
Helsinki 163
San Diego 155
Frankfurt am Main 141
London 136
Kunming 135
Boulder 130
Redwood City 127
Lagos 123
Lancaster 123
Falls Church 122
Rome 122
Munich 120
Dakar 116
Pune 111
Ogden 108
Shenyang 104
Vienna 104
Hebei 96
Brussels 94
Changsha 84
Tianjin 80
Chicago 77
Jiaxing 68
Norwalk 62
Rio de Janeiro 59
Nuremberg 54
Auburn Hills 52
Hangzhou 52
Fuzhou 51
Jinan 50
Phoenix 50
Brasília 49
Orange 46
Turku 46
Belo Horizonte 45
Brooklyn 45
San Francisco 41
Tashkent 40
Da Nang 38
Baghdad 37
Curitiba 37
Marseille 37
Düsseldorf 36
Atlanta 35
Verona 35
Guangzhou 34
Detroit 33
Haiphong 33
Orem 33
Totale 58.670
Salva come PNG Salva come JPEG
Nome #
European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group 911
Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. 331
T cell immunoregulation in rheumatoid synovitis. 258
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. 236
VALUTAZIONE DELL’ASTENIA IN PAZIENTI AFFETTI DA SPONDILOARTRITE 233
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 230
Depression and systemic lupus erythematosus: a systematic review 227
[Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis] 223
Oral sildenafil in skin ulcers secondary to systemic sclerosis. 215
Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. 213
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 212
Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study 205
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. 200
Antinflammatory therapy and cardiovascular risk: a consensus view 199
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 199
Fibromyalgia features in patients with primary Sjögren's syndrome. Evidence of a relationship with psychological depression. 198
Comment on: Disease Activity Criteria in Scleroderma 198
Antipolymer antibody in Italian fibromyalgic patients 198
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study) 197
Classification criteria 197
Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. 196
Association between polyarteritis and Australia antigen. 195
A proposal of simple calculation (ERI calculator) to predict the early response to TNF-a blockers therapy in rheumatoid arthritis 194
A unified list of acronyms for the rheumatology literature. 193
Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial 193
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 192
The promising role of lung Ultrasound in Systemic Sclerosis 191
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 190
A method for retracing the putative antigen/antibody ratio of immune complexes in biological fluids. 189
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients 189
Skin manifestations and sjögren’s syndrome 189
Hepatitis C virus, autoimmune liver disease and cryoglobulinaemic hepatitis. 187
Comparison of masticatory dysfunction in temporomandibular disorders and fibromyalgia 187
Xerosis in primary Sjogren syndrome; immunohistochemical and functional investigations 187
Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. 186
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 186
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 185
MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. [MALDI-TOF e SELDI-TOF: due tecniche “tandem” per l’individuazione di potenziali biomarker nella fibromialgia] 185
HLA antigens in Italian patients with primary Sjögren's syndrome. 183
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 183
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 183
Activity criteria in systemic lupus erythematosus 182
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints. 182
Subthreshold mood symptoms in patients with fibromyalgia and rheumatoid arthritis. 181
Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. 180
[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome] 180
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 180
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 180
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. 180
Lung function abnormalities in different connective tissue diseases. 179
Ultrasound imaging for the rheumatologist X. Ultrasound imaging in crystal-related arthropathies 179
A multidisciplinary approach to study the effects of balneotherapy and mud-bath therapy treatments on fibromyalgia. 179
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 179
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database 178
Misdiagnosis in fibromyalgia: a multicentre study 178
Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients 177
Skin manifestations and cryoglobulinemia 177
A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles 176
A plasma cell granuloma in a patient with Sjögren's syndrome. 175
Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia 175
Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? 175
ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN IMAGING POINT OF VIEW 175
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers 175
Anti-Sm and anti-RNP antibodies 175
A SIMPLE METHOD FOR THE BIOCHEMICAL PURIFICATION OF RO/SS-A ANTIGEN 175
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 174
Lung function in essential mixed cryoglobulinemia: a short-term follow-up. 174
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes] 174
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study 174
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 173
Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations. 172
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 172
Biomarkers for Sjögren's syndrome 172
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus 172
A technique for immunoassay of human IgG. 171
[Renal tubular acidosis in essential mixed cryoglobulinemia]. 171
Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange 171
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy 171
Preliminary classification criteria for the cryoglobulinaemic vasculitis. 170
Fibromialgia, fattori neurotrofici e disturbi dell’umore 170
Undifferentiated connective tissue diseases (UCTD) 170
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 170
Long-term griseofulvin treatment for progressive systemic sclerosis. 170
Alteration of serotonin transporter density and activity in fibromyalgia. 169
A case of adult periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome associated with endocapillary proliferative glomerulonephritis 169
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype 169
Mixed cryoglobulinemia and mortality: a review of the literature 168
Quantitative evaluation of 99mTc-pyrophosphate muscle uptake in patients with inflammatory and noninflammatory muscle diseases. 167
Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome. 167
Alteration of peripheral benzodiazepine receptor density and of calcium, magnesium, ATP levels in fibromyalgia. 167
US Examination of Wrists and Hands: a Comparison Between Rheumatoid Arthritis and Psoriatic Arthritis 167
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia 167
Anti-collagen antibodies in systemic sclerosis and in primary Raynaud's phenomenon. 167
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 167
Prevalence of anticardiolipin antibodies in coronary artery disease. 166
Slow-releasing nicardipine in the treatment of Raynaud's phenomena without underlying diseases. 166
The targets of nephritogenic antibodies in systemic autoimmune disorders 166
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis 166
Circulating Immune-Complexes In Mixed Cryoglobulinemia 165
Differences in pharmacology of tumor necrosis factor (TNF) antagonists 165
Totale 19.244
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.988 61 444 74 428 1.177 829 150 327 312 137 278 1.771
2022/20237.483 884 872 415 877 1.021 1.076 52 597 1.149 37 431 72
2023/20245.416 911 608 727 316 774 960 103 158 116 89 123 531
2024/202516.131 37 683 112 953 1.383 1.424 1.517 1.002 1.768 2.304 2.010 2.938
2025/202615.730 1.030 2.443 1.953 956 1.544 1.620 2.835 641 770 1.144 494 300
2026/202781 81 0 0 0 0 0 0 0 0 0 0 0
Totale 80.088